Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
In men, main risk factors for metabolic syndrome include abdominal obesity, high blood sugar, high triglycerides, low HDL cholesterol, high blood pressure, alcohol drinking, and…
Yes, a mobile app plus group sessions is feasible and well-accepted for managing GDM, though evidence on long-term outcomes is still emerging.
In poorer nations, key GDM risk factors include advanced maternal age, pre-pregnancy obesity, family history of diabetes, prior GDM, urban residence, and physical inactivity.
Yes, semaglutide can reduce total daily insulin dose in adults with type 1 diabetes and overweight or obesity, based on clinical trial and real-world data.
Yes, the FDA-approved drug Tzield (teplizumab) delays the onset of Stage 3 type 1 diabetes in people with Stage 2 disease.
No, extending sleep by about 1 hour per night for 6 weeks did not change insulin sensitivity in people with overweight or obesity who were short sleepers.
Yes, switching to integrase inhibitors (INSTIs) is linked to an increased risk of developing diabetes in people with HIV, based on recent studies.
Standard treatment for type 2 diabetes includes lifestyle changes (diet, exercise), metformin, other medications like GLP-1 agonists (e.g., semaglutide, tirzepatide), and…
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.